All ETFs

CNCR

ETF

CNCR · UNKNOWN · 75 holdings

About CNCR

No description available for this ETF.

Fund Details

Expense Ratio: —
Inception Date: —
Exchange: UNKNOWN
Currency: USD
Holdings As Of: Apr 10, 2026
Tracked Holdings: 88.0%
HHI Score: 166,61
Top Sector: Healthcare (61.770767%)

Performance

Moderate (40,8%) → Stabilizing

0,00%

▼ -9,35%

▼ -19,96%

▼ -32,84%

YTD

▼ -26,73%

▼ -38,13%

▼ -35,98%

1M loss (-9.35%) is smaller than 3M (-19.96%) — decline may be easing

Concentration Risk

26,85% Balanced

Diversified Concentrated

The top 10 holdings represent 26,85% of the fund. This ETF is well diversified across its holdings, reducing single-stock risk.

Top Holdings Today

Weighted by position size

RXRX

▼ -0,91%

PGEN

▼ -2,58%

CMPX

▼ -5,14%

GNLX

▼ -0,78%

EXEL

▼ -2,51%

DNA

▲ 0,31%

REPL

▼ -19,46%

BMY

▼ -1,43%

SDGR

▼ -0,87%

Weighted avg. of top holdings ▼ -3,37%

Sector Allocation

Healthcare

61,77%

Manufacturing

27,06%

Top 10 Holdings

26,85% of fund

RXRX Recursion Pharmaceuticals Inc

4,01%

PGEN Precigen Inc

3,05%

CMPX Compass Therapeutics Inc

2,99%

GNLX Genelux Corp

2,90%

SWTX SpringWorks Therapeutics Inc

2,86%

EXEL Exelixis Inc

2,48%

DNA Ginkgo Bioworks Holdings Inc

2,33%

REPL Replimune Group Inc

2,14%

BMY Bristol-Myers Squibb Co

2,10%

SDGR Schrodinger Inc/United States

1,98%

Other positions

0,65%

All Holdings (75)

Top 10: 26,85% of fund

#	Ticker	Name	Weight	Shares	Market Value
1	RXRX	Recursion Pharmaceuticals Inc	4,01%	47.707	358.279,57
2	PGEN	Precigen Inc	3,05%	157.416	272.329,68
3	CMPX	Compass Therapeutics Inc	2,99%	92.038	266.910,2
4	GNLX	Genelux Corp	2,90%	61.963	259.005,34
5	SWTX	SpringWorks Therapeutics Inc	2,86%	4.426	255.645,76
6	EXEL	Exelixis Inc	2,48%	5.730	221.693,7
7	DNA	Ginkgo Bioworks Holdings Inc	2,33%	25.263	208.167,12
8	REPL	Replimune Group Inc	2,14%	15.047	190.795,96
9	BMY	Bristol-Myers Squibb Co	2,10%	3.149	187.743,38
10	SDGR	Schrodinger Inc/United States	1,98%	7.925	176.806,75
11	BPMC	Blueprint Medicines Corp	1,97%	1.824	176.143,68
12	ZYME	Zymeworks Inc	1,89%	12.581	168.585,4
13	VOR	Vor BioPharma Inc	1,88%	155.827	168.293,16
14	HCM	HUTCHMED China Ltd	1,76%	9.522	156.732,12
15	IPHA	Innate Pharma SA	1,73%	72.695	154.113,4
16	GLUE	Monte Rosa Therapeutics Inc	1,73%	28.005	154.027,5
17	IBRX	ImmunityBio Inc	1,66%	45.097	148.369,13
18	MRUS	Merus NV	1,65%	3.136	147.674,24
19	ELVN	Enliven Therapeutics Inc	1,64%	7.033	146.497,39
20	RVMD	Revolution Medicines Inc	1,61%	3.534	143.975,16
21	BNTX	BioNTech SE	1,61%	1.275	143.973,0
22	IMCR	Immunocore Holdings PLC	1,57%	4.770	140.094,9
23	SNDX	Syndax Pharmaceuticals Inc	1,51%	8.648	135.254,72
24	GMAB	Genmab A/S	1,50%	5.921	134.288,28
25	ACLX	Arcellx Inc	1,48%	2.045	132.556,9
26	MRK	Merck & Co Inc	1,38%	1.335	123.153,75
27	INBX	Inhibrx Biosciences Inc	1,34%	9.030	119.647,5
28	AURA	Aura Biosciences Inc	1,32%	15.787	118.244,63
29	XNCR	Xencor Inc	1,28%	7.442	114.309,12
30	MGNX	MacroGenics Inc	1,26%	45.885	112.877,1
31	ALLO	Allogene Therapeutics Inc	1,25%	57.024	111.196,8
32	ARVN	Arvinas Inc	1,24%	6.259	110.784,3
33	SMMT	Summit Therapeutics Inc	1,24%	5.340	110.484,6
34	KPTI	Karyopharm Therapeutics Inc	1,22%	13.708	108.980,72
35	LEGN	Legend Biotech Corp	1,20%	3.069	107.445,69
36	NUVL	Nuvalent Inc	1,18%	1.404	105.271,92
37	DAWN	Day One Biopharmaceuticals Inc	1,17%	11.547	104.615,82
38	JANX	Janux Therapeutics Inc	1,16%	3.155	103.767,95
39	KYMR	Kymera Therapeutics Inc	1,14%	3.247	101.793,45
40	ACRV	Acrivon Therapeutics Inc	1,14%	19.124	101.548,44
41	RCUS	Arcus Biosciences Inc	1,14%	9.313	101.418,57
42	NUVB	Nuvation Bio Inc	1,13%	51.266	100.994,02
43	REGN	Regeneron Pharmaceuticals Inc	1,07%	137	95.727,38
44	NRIX	Nurix Therapeutics Inc	1,07%	6.187	95.589,15
45	RAPT	RAPT Therapeutics Inc	1,07%	83.716	95.436,24
46	ITOS	iTeos Therapeutics Inc	1,06%	13.008	94.438,08
47	ACET	Adicet Bio Inc	1,06%	104.924	94.305,69
48	TYRA	Tyra Biosciences Inc	1,02%	7.811	91.466,81
49	CRBU	Caribou Biosciences Inc	1,02%	77.530	90.710,1
50	IMRX	Immuneering Corp	1,01%	54.838	90.482,7
51	LYEL	Lyell Immunopharma Inc	1,01%	126.923	90.216,87
52	ZNTL	Zentalis Pharmaceuticals Inc	0,99%	42.768	88.529,76
53	IDYA	Ideaya Biosciences Inc	0,98%	4.274	87.916,18
54	TSVT	2seventy bio Inc	0,97%	32.721	86.383,44
55	FHTX	Foghorn Therapeutics Inc	0,92%	16.997	82.435,45
56	CGEM	Cullinan Therapeutics Inc	0,88%	9.296	78.923,04
57	APLM	Apollomics Inc	0,87%	11.835	78.111,0
58	ERAS	Erasca Inc	0,86%	55.811	76.461,07
59	AGEN	Agenus Inc	0,83%	25.886	73.775,1
60	BCYC	Bicycle Therapeutics PLC	0,77%	6.304	69.154,88
61	AUTL	Autolus Therapeutics PLC	0,76%	39.347	68.070,31
62	IOVA	Iovance Biotherapeutics Inc	0,76%	16.044	67.946,34
63	STRO	Sutro Biopharma Inc	0,76%	42.537	67.633,83
64	YMAB	Y-mAbs Therapeutics Inc	0,75%	12.098	67.264,88
65	RLAY	Relay Therapeutics Inc	0,74%	19.407	66.177,87
66	GERN	Geron Corp	0,71%	36.015	63.386,4
67	KURA	Kura Oncology Inc	0,65%	7.542	58.148,82
68	BMEA	Biomea Fusion Inc	0,64%	19.723	56.999,47
69	RPTX	Repare Therapeutics Inc	0,63%	47.406	55.939,08
70	IMTX	Immatics NV	0,61%	12.364	54.154,32
71	PRLD	Prelude Therapeutics Inc	0,51%	60.533	45.944,55
72	FATE	Fate Therapeutics Inc	0,50%	39.744	44.513,28
73	MRSN	Mersana Therapeutics Inc	0,47%	79.891	41.814,95
74	TNGX	Tango Therapeutics Inc	0,38%	16.378	33.902,46
75	IGMS	IGM Biosciences Inc	0,15%	9.936	13.512,96

Showing top 10 of 75 holdings · Listed: 99,35% · 0,65% in other positions

Related ETFs

IWV

iShares Russell 3000 ETF

Vanguard Russell 3000 ETF